Home Markets Regeneron slides as Amgen wins Eylea biosimilar case; RBC still bullish

Regeneron slides as Amgen wins Eylea biosimilar case; RBC still bullish

Sep 24, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/regeneron-slides-as-amgen-wins-eylea-biosimilar-case-rbc-still-bullish-3628943

You May Also Like

Paramount seeks FCC approval for foreign investors backing Warner Bros acquisition

Wall St futures tick up after record highs; Iran’s Hormuz proposal in focus

Dynatrace shares rise on report of activist Starboard stake

Trump says ABC should fire late-night host Kimmel

Explainer-What does Bayer’s US Supreme Court case mean for the thousands of Roundup lawsuits?

Rogers Communications offering buyouts to half its workforce, Globe and Mail reports